These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 14764967)

  • 1. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of fatal hemolytic disease of the newborn associated with-D-/-D-phenotype.
    Han KS; Kim HC; Han KS; Shim WS
    Am J Perinatol; 1997 Sep; 14(8):495-7. PubMed ID: 9376014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of rhesus alloimmunization in pregnancy.
    Moise KJ
    Obstet Gynecol; 2008 Jul; 112(1):164-76. PubMed ID: 18591322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
    Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
    Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of a full-term infant with hemolytic disease of the newborn due to an anti-Rh17 antibody in a mother with D-- phenotype.
    Shah SI; Caprio M; Strauss R; Moskowitz N
    Am J Hematol; 2005 Sep; 80(1):88-9. PubMed ID: 16138349
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monitoring and treatment of fetal maternal allo-immunization. Role of cordocentesis].
    Donner C; Lambermont M; Karioun A; Paquet V; Vermeylen D; Rodesch F
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(8):892-7. PubMed ID: 7706659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
    Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
    J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New possibilities in diagnosing hemolytic disease of newborn infants].
    Fischer K; Poschmann A; Grundmann A; Asmussen S
    Beitr Infusionsther; 1992; 30():431-5. PubMed ID: 1284753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine transfusion in an Rh-immunized twin pregnancy: a case report of successful outcome and a review of the literature.
    Manning FA; Bowman JM; Lange IR; Chamberlain PF
    Obstet Gynecol; 1985 Mar; 65(3 Suppl):2S-6S. PubMed ID: 3919348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17.
    Li BJ; Jiang YJ; Yuan F; Ye HX
    Transfus Med; 2010 Feb; 20(1):66-9. PubMed ID: 19725902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern diagnosis and therapy of fetomaternal blood group incompatibility].
    Vetter K; Favre Y
    Arch Gynecol Obstet; 1990; 247 Suppl():S25-35. PubMed ID: 2128174
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD; Gordon MC; Higby K
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pregnancies complicated by anti-c isoimmunization.
    Hackney DN; Knudtson EJ; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2004 Jan; 103(1):24-30. PubMed ID: 14704240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
    Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB
    Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.